Ligand Pharm (LGND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LGND | AMGN | BMY | GILD | VRTX |
| Company | Ligand Pharm | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 79.27 | 309.53 | 43.56 | 65.18 | 419.00 |
| High | 83.98 | 314.18 | 44.36 | 65.22 | 421.18 |
| Low | 79.27 | 306.32 | 43.50 | 64.61 | 416.03 |
| Last | 84.33 | 313.82 | 44.39 | 64.67 | 419.03 |
| Change | +3.97 | +6.51 | +0.72 | -0.25 | +0.21 |
| % Change | +4.94% | +2.12% | +1.65% | -0.39% | +0.05% |
| Volume | 319,737 | 1,409,387 | 5,103,048 | 2,648,067 | 334,809 |
| 20-Day Average Volume | 164,028 | 2,826,659 | 14,060,503 | 7,285,175 | 1,096,192 |
| Previous Close | 80.36 | 307.31 | 43.67 | 64.92 | 418.82 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 74.14 | 279.52 | 46.15 | 66.11 | 400.61 |
| 20-Day Raw Stochastic | 94.46% | 85.89% | 15.77% | 10.37% | 79.65% |
| 20-Day Relative Strength | 64.10% | 68.38% | 33.17% | 32.33% | 59.78% |
| Weighted Alpha | +21.36 | +36.26 | -35.55 | -21.29 | +21.26 |
| Today's Opinion | 88% Buy | 56% Buy | 100% Sell | 100% Sell | 56% Buy |
| Previous Opinion | 80% Buy | 56% Buy | 100% Sell | 100% Sell | 56% Buy |
| Last Month's Opinion | 88% Buy | 40% Sell | 48% Sell | 100% Sell | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +14.88% since 05/02/24 | +12.74% since 05/02/24 | +1.41% since 05/02/24 | -0.85% since 05/02/24 | +4.61% since 05/02/24 |
| Low | 72.57 on 05/03/24 | 297.52 on 05/06/24 | 43.49 on 05/09/24 | 64.33 on 05/03/24 | 394.03 on 05/07/24 |
| High | 83.98 on 05/09/24 | 322.60 on 05/03/24 | 44.62 on 05/06/24 | 66.14 on 05/07/24 | 425.65 on 05/08/24 |
| 1-Month | |||||
| %Chg | +1.94% since 04/09/24 | +16.09% since 04/09/24 | -14.12% since 04/09/24 | -7.38% since 04/09/24 | +3.49% since 04/09/24 |
| Low | 67.72 on 04/22/24 | 260.68 on 04/19/24 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 |
| High | 83.98 on 05/09/24 | 322.60 on 05/03/24 | 51.28 on 04/10/24 | 69.76 on 04/10/24 | 425.65 on 05/08/24 |
| 3-Month | |||||
| %Chg | +9.49% since 02/09/24 | +7.81% since 02/09/24 | -11.03% since 02/09/24 | -12.07% since 02/09/24 | -1.02% since 02/09/24 |
| Low | 67.72 on 04/22/24 | 260.68 on 04/19/24 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 |
| High | 94.57 on 02/27/24 | 322.60 on 05/03/24 | 55.03 on 03/13/24 | 76.21 on 03/11/24 | 437.00 on 02/27/24 |
| 6-Month | |||||
| %Chg | +52.05% since 11/09/23 | +18.86% since 11/09/23 | -12.09% since 11/09/23 | -13.61% since 11/09/23 | +13.57% since 11/09/23 |
| Low | 52.97 on 11/10/23 | 260.52 on 11/21/23 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 341.90 on 11/16/23 |
| High | 94.57 on 02/27/24 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,422,773 | 164,851,840 | 88,523,448 | 80,830,400 | 108,247,808 |
| Shares Outstanding, K | 17,705 | 536,435 | 2,027,100 | 1,245,077 | 258,459 |
| Annual Sales | 131,310,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | 52,150,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 28,100,000 | 7,447,000,000 | 11,865,000,000 | 6,686,000,000 | 2,517,700,000 |
| Last Quarter Net Income | 18,190,000 | -113,000,000 | -11,911,000,000 | -4,170,000,000 | 968,800,000 |
| 60-Month Beta | 1.01 | 0.60 | 0.45 | 0.22 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | 3.84 on 05/07/24 | 3.96 on 05/02/24 | -4.40 on 04/25/24 | -1.32 on 04/25/24 | 4.76 on 05/06/24 |
| Latest Earnings Date | 05/07/24 | 05/02/24 | 04/25/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | 2.500 on 04/03/07 | 2.250 on 02/15/24 | 0.600 on 04/04/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 04/04/24 | 06/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 21.54 | 16.12 | 41.94 | 16.24 | 27.24 |